{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:33:19Z","timestamp":1787236399643,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008375","name":"University of Basel","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008375","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Trephine bone marrow biopsies (TBMB) are standard specimens for diagnostics and follow-up of myeloid and precursor cell neoplasms, usually as part of a multimodal approach including complete blood count (CBC) tests, cytologic assessment of BM aspirate smears, flow cytometry, cytogenomics, and molecular genetics. Incorporating the results of all the above methods or running all tests within one specialized lab and providing an integrative report is ideally desirable. However, in reality, in many countries, (1) diagnostic (hemato-)pathologists may not have access to information on the results obtained by other technologies except for a CBC, (2) individual procedures may not be available at all, (3) specimens may not be submitted to specialized labs, or (4) particular technologies may fail yielding results (e.g., dry taps or specimens with destroyed nucleic acids), so that the TBMB might remain the only analytic sample. The detailed description of our approach to handling TBMB including classic histopathology, immunohistochemistry, fluorescence in situ hybridization, and sequencing techniques in the setting of myeloid and precursor neoplasms may help the readership to\u00a0achieve a comprehensive TBMB diagnostic approach reaching more definite and robust conclusions to improve patient care.<\/jats:p>","DOI":"10.1007\/s12308-025-00663-5","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:47:42Z","timestamp":1760734062000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Practical diagnostic approach to assess myeloid and precursor cell neoplasms on trephine bone marrow biopsies: reflection of middle European reality"],"prefix":"10.1007","volume":"18","author":[{"given":"Thomas","family":"Menter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandar","family":"Tzankov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"issue":"2","key":"663_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/01.pas.0000213338.25111.d3","volume":"31","author":"S Aboudola","year":"2007","unstructured":"Aboudola S (2007) Bone marrow phospho-STAT5 expression in non-CML chronic myeloproliferative disorders correlates with JAK2 V617F mutation and provides evidence of in vivo JAK2 activation. Am J Surg Pathol 31(2):233\u2013239","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"663_CR2","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/jclinpath-2019-206340","volume":"73","author":"IA Abukhiran","year":"2020","unstructured":"Abukhiran IA, Jasser J, Syrbu S (2020) Paraneoplastic leukemoid reactions induced by cytokine-secreting tumours. J Clin Pathol 73(6):310\u2013313","journal-title":"J Clin Pathol"},{"issue":"4","key":"663_CR3","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1365-2141.2011.08760.x","volume":"154","author":"S Al-Shieban","year":"2011","unstructured":"Al-Shieban S et al (2011) Immunohistochemical distinction of haematogones from B lymphoblastic leukaemia\/lymphoma or B-cell acute lymphoblastic leukaemia (B-ALL) on bone marrow trephine biopsies: a study on 62 patients. Br J Haematol 154(4):466\u2013470","journal-title":"Br J Haematol"},{"issue":"20","key":"663_CR4","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA et al (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391\u20132405","journal-title":"Blood"},{"issue":"11","key":"663_CR5","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA et al (2022) International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood 140(11):1200\u20131228","journal-title":"Blood"},{"issue":"5","key":"663_CR6","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1309\/EM7KCQR4GLMHRCX4","volume":"119","author":"DA Arber","year":"2003","unstructured":"Arber DA et al (2003) Prognostic impact of acute myeloid leukemia classification. Importance of detection of recurring cytogenetic abnormalities and multilineage dysplasia on survival. Am J Clin Pathol 119(5):672\u2013680","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"663_CR7","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00428-017-2075-5","volume":"470","author":"A Bodmer","year":"2017","unstructured":"Bodmer A (2017) Sharing of a PTPN11 mutation by myelodysplastic bone marrow and a mature plasmacytoid dendritic cell proliferation provides evidence for their common myelomonocytic origin. Virchows Arch 470(4):469\u2013473","journal-title":"Virchows Arch"},{"issue":"1","key":"663_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/modpathol.2011.128","volume":"25","author":"L Boiocchi","year":"2012","unstructured":"Boiocchi L (2012) Thrombopoietin receptor agonist therapy in primary immune thrombocytopenia is associated with bone marrow hypercellularity and mild reticulin fibrosis but not other stromal abnormalities. Mod Pathol 25(1):65\u201374","journal-title":"Mod Pathol"},{"issue":"2","key":"663_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s12308-016-0270-y","volume":"9","author":"VI de Laak-de","year":"2016","unstructured":"de Laak-de VI et al (2016) How we do: optimizing bone marrow biopsy logistics for sign-out within 2 days. J Hematop 9(2):67\u201371","journal-title":"J Hematop"},{"issue":"5","key":"663_CR10","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1200\/JCO.2008.18.2246","volume":"27","author":"MG Della Porta","year":"2009","unstructured":"Della Porta MG (2009) Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes. J Clin Oncol 27(5):754\u2013762","journal-title":"J Clin Oncol"},{"issue":"12","key":"663_CR11","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H Dohner","year":"2022","unstructured":"Dohner H et al (2022) Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood 140(12):1345\u20131377","journal-title":"Blood"},{"issue":"5","key":"663_CR12","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1111\/ijlh.13508","volume":"43","author":"B Drexler","year":"2021","unstructured":"Drexler B et al (2021) Blast counts are lower in the aspirate as compared to trephine biopsy in acute myeloid leukemia and myelodysplastic syndrome expressing CD56. Int J Lab Hematol 43(5):1078\u20131084","journal-title":"Int J Lab Hematol"},{"issue":"21","key":"663_CR13","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1182\/blood.2022015853","volume":"140","author":"EJ Duncavage","year":"2022","unstructured":"Duncavage EJ (2022) Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia. Blood 140(21):2228\u20132247","journal-title":"Blood"},{"issue":"5","key":"663_CR14","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/bjh.18632","volume":"200","author":"S El Hussein","year":"2023","unstructured":"El Hussein S, Wang W (2023) Plasmacytoid dendritic cells in the setting of myeloid neoplasms: diagnostic guide to challenging pathologic presentations. Br J Haematol 200(5):545\u2013555","journal-title":"Br J Haematol"},{"issue":"4","key":"663_CR15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.pathol.2022.03.002","volume":"54","author":"AK Enjeti","year":"2022","unstructured":"Enjeti AK (2022) Panel-based gene testing in myelodysplastic\/myeloproliferative neoplasm overlap syndromes: Australasian leukaemia and lymphoma group (ALLG) consensus statement. Pathology 54(4):389\u2013398","journal-title":"Pathology"},{"issue":"2","key":"663_CR16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/modpathol.2015.145","volume":"29","author":"F Facchetti","year":"2016","unstructured":"Facchetti F et al (2016) Neoplasms derived from plasmacytoid dendritic cells. Mod Pathol 29(2):98\u2013111","journal-title":"Mod Pathol"},{"issue":"2","key":"663_CR17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3324\/haematol.13855","volume":"94","author":"F Facchetti","year":"2009","unstructured":"Facchetti F et al (2009) Cytoplasmic nucleophosmin is not detected in blastic plasmacytoid dendritic cell neoplasm. Haematologica 94(2):285\u2013288","journal-title":"Haematologica"},{"issue":"1","key":"663_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000530940","volume":"91","author":"C Faria","year":"2024","unstructured":"Faria C, Tzankov A (2024) Progression in myeloid neoplasms: beyond the myeloblast. Pathobiology 91(1):55\u201375","journal-title":"Pathobiology"},{"issue":"7","key":"663_CR19","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.humpath.2007.10.034","volume":"39","author":"SE Gibson","year":"2008","unstructured":"Gibson SE (2008) Phospho-STAT5 expression pattern with the MPL W515L mutation is similar to that seen in chronic myeloproliferative disorders with JAK2 V617F. Hum Pathol 39(7):1111\u20131114","journal-title":"Hum Pathol"},{"key":"663_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2025.105766","volume":"158","author":"H Hamdan","year":"2025","unstructured":"Hamdan H (2025) Investigation of NPM1 mutation frequency in cutaneous blastic plasmacytoid dendritic cell neoplasms. Hum Pathol 158:105766","journal-title":"Hum Pathol"},{"issue":"3","key":"663_CR21","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/path.1126","volume":"197","author":"M Hashimoto","year":"2002","unstructured":"Hashimoto M, Yamashita Y, Mori N (2002) Immunohistochemical detection of CD79a expression in precursor T cell lymphoblastic lymphoma\/leukaemias. J Pathol 197(3):341\u2013347","journal-title":"J Pathol"},{"issue":"10","key":"663_CR22","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.humpath.2005.07.020","volume":"36","author":"S Heiss","year":"2005","unstructured":"Heiss S, Erdel M, Gunsilius E, Nachbaur D, Tzankov A (2005) Myelodysplastic\/myeloproliferative disease with erythropoietic hyperplasia (erythroid preleukemia) and the unique translocation (8;9)(p23;p24): first description of a case. Hum Pathol 36(10):1148\u20131151","journal-title":"Hum Pathol"},{"issue":"2","key":"663_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1309\/AJCPR3N3JMSYLPFG","volume":"137","author":"D Hoehn","year":"2012","unstructured":"Hoehn D (2012) CD117 expression is a sensitive but nonspecific predictor of FLT3 mutation in T acute lymphoblastic leukemia and T\/myeloid acute leukemia. Am J Clin Pathol 137(2):213\u2013219","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"663_CR24","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s00277-016-2682-2","volume":"95","author":"A Janssens","year":"2016","unstructured":"Janssens A et al (2016) Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia. Ann Hematol 95(7):1077\u20131087","journal-title":"Ann Hematol"},{"issue":"4","key":"663_CR25","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/PAS.0000000000000358","volume":"39","author":"AG Jegalian","year":"2015","unstructured":"Jegalian AG, Bodo J, Hsi ED (2015) NOTCH1 intracellular domain immunohistochemistry as a diagnostic tool to distinguish T-lymphoblastic lymphoma from thymoma. Am J Surg Pathol 39(4):565\u2013572","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"663_CR26","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1097\/PAS.0000000000001765","volume":"45","author":"SG Katz","year":"2021","unstructured":"Katz SG, Edappallath S, Xu ML (2021) IRF8 is a reliable monoblast marker for acute monocytic leukemias. Am J Surg Pathol 45(10):1391\u20131398","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"663_CR27","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD et al (2022) The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia 36(7):1703\u20131719","journal-title":"Leukemia"},{"issue":"6","key":"663_CR28","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/his.12871","volume":"68","author":"HM Kvasnicka","year":"2016","unstructured":"Kvasnicka HM et al (2016) Problems and pitfalls in grading of bone marrow fibrosis, collagen deposition and osteosclerosis - a consensus-based study. Histopathology 68(6):905\u2013915","journal-title":"Histopathology"},{"issue":"10","key":"663_CR29","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1038\/s41375-019-0447-3","volume":"33","author":"N Lucas","year":"2019","unstructured":"Lucas N et al (2019) Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemia. Leukemia 33(10):2466\u20132480","journal-title":"Leukemia"},{"issue":"3","key":"663_CR30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11899-021-00618-4","volume":"16","author":"AA Mangaonkar","year":"2021","unstructured":"Mangaonkar AA, Tande AJ, Bekele DI (2021) Differential diagnosis and workup of monocytosis: a systematic approach to a common hematologic finding. Curr Hematol Malig Rep 16(3):267\u2013275","journal-title":"Curr Hematol Malig Rep"},{"issue":"2\u20133","key":"663_CR31","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000493688","volume":"86","author":"T Menter","year":"2019","unstructured":"Menter T et al (2019) RUNX1 mutations can lead to aberrant expression of CD79a and PAX5 in acute myelogenous leukemias: a potential diagnostic pitfall. Pathobiology 86(2\u20133):162\u2013166","journal-title":"Pathobiology"},{"issue":"11","key":"663_CR32","doi-asserted-by":"publisher","first-page":"e434","DOI":"10.3324\/haematol.2015.130112","volume":"100","author":"A Nazha","year":"2015","unstructured":"Nazha A et al (2015) Genomic patterns associated with hypoplastic compared to hyperplastic myelodysplastic syndromes. Haematologica 100(11):e434\u2013e437","journal-title":"Haematologica"},{"issue":"4","key":"663_CR33","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/ajcp\/aqx021","volume":"147","author":"MJ Oberley","year":"2017","unstructured":"Oberley MJ et al (2017) Clinical significance of isolated myeloperoxidase expression in pediatric B-lymphoblastic leukemia. Am J Clin Pathol 147(4):374\u2013381","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"663_CR34","first-page":"417","volume":"11","author":"EN Oliva","year":"2021","unstructured":"Oliva EN et al (2021) Accuracy of bone marrow histochemical TP53 expression compared to the detection of TP53 somatic mutations in patients with myelodysplastic syndromes harbouring a del5q cytogenetic abnormality. Am J Blood Res 11(4):417\u2013426","journal-title":"Am J Blood Res"},{"issue":"12","key":"663_CR35","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1038\/modpathol.3800707","volume":"19","author":"A Orazi","year":"2006","unstructured":"Orazi A et al (2006) Chronic myelomonocytic leukemia: the role of bone marrow biopsy immunohistology. Mod Pathol 19(12):1536\u20131545","journal-title":"Mod Pathol"},{"issue":"3","key":"663_CR36","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1200\/JCO.2010.31.2686","volume":"29","author":"JR Passweg","year":"2011","unstructured":"Passweg JR et al (2011) Immunosuppressive therapy for patients with myelodysplastic syndrome: a prospective randomized multicenter phase III trial comparing antithymocyte globulin plus cyclosporine with best supportive care\u2013SAKK 33\/99. J Clin Oncol 29(3):303\u2013309","journal-title":"J Clin Oncol"},{"issue":"13","key":"663_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35950","volume":"131","author":"SA Patel","year":"2025","unstructured":"Patel SA et al (2025) Early identification of TP53 mutations and TP53 allelic state in myelodysplastic neoplasms and acute myeloid leukemia via point-of-care p53 immunohistochemistry. Cancer 131(13):e35950","journal-title":"Cancer"},{"issue":"7","key":"663_CR38","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/s41379-020-0498-z","volume":"33","author":"SS Patel","year":"2020","unstructured":"Patel SS et al (2020) Multiparametric in situ imaging of NPM1-mutated acute myeloid leukemia reveals prognostically-relevant features of the marrow microenvironment. Mod Pathol 33(7):1380\u20131388","journal-title":"Mod Pathol"},{"issue":"8","key":"663_CR39","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/ajh.25544","volume":"94","author":"SS Patel","year":"2019","unstructured":"Patel SS et al (2019) High NPM1 mutant allele burden at diagnosis correlates with minimal residual disease at first remission in de novo acute myeloid leukemia. Am J Hematol 94(8):921\u2013928","journal-title":"Am J Hematol"},{"issue":"4","key":"663_CR40","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00428-009-0726-x","volume":"454","author":"M Qubaja","year":"2009","unstructured":"Qubaja M et al (2009) The detection of CD14 and CD16 in paraffin-embedded bone marrow biopsies is useful for the diagnosis of chronic myelomonocytic leukemia. Virchows Arch 454(4):411\u2013419","journal-title":"Virchows Arch"},{"issue":"6","key":"663_CR41","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3324\/haematol.2013.098103","volume":"99","author":"L Saft","year":"2014","unstructured":"Saft L (2014) P53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q). Haematologica 99(6):1041\u20131049","journal-title":"Haematologica"},{"issue":"1","key":"663_CR42","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/leu.2015.192","volume":"30","author":"H Stein","year":"2016","unstructured":"Stein H et al (2016) A new monoclonal antibody (CAL2) detects CALRETICULIN mutations in formalin-fixed and paraffin-embedded bone marrow biopsies. Leukemia 30(1):131\u2013135","journal-title":"Leukemia"},{"issue":"8","key":"663_CR43","first-page":"1128","volume":"90","author":"J Thiele","year":"2005","unstructured":"Thiele J et al (2005) European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica 90(8):1128\u20131132","journal-title":"Haematologica"},{"issue":"4","key":"663_CR44","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/ijlh.12365","volume":"37","author":"EE Torlakovic","year":"2015","unstructured":"Torlakovic EE et al (2015) ICSH guidelines for the standardization of bone marrow immunohistochemistry. Int J Lab Hematol 37(4):431\u2013449","journal-title":"Int J Lab Hematol"},{"issue":"5","key":"663_CR45","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/PAS.0000000000001874","volume":"46","author":"A Tzankov","year":"2022","unstructured":"Tzankov A, Facchetti F, Muhleisen B, Dirnhofer S (2022) IRF8 is a reliable monoblast marker for acute monocytic leukemias, but does not discriminate between monoblasts and plasmacytoid dendritic cells. Am J Surg Pathol 46(5):725\u2013727","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"663_CR46","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.3324\/haematol.2019.222059","volume":"104","author":"P Valent","year":"2019","unstructured":"Valent P et al (2019) Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions. Haematologica 104(10):1935\u20131949","journal-title":"Haematologica"},{"issue":"8","key":"663_CR47","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/ajh.26966","volume":"98","author":"SA Wang","year":"2023","unstructured":"Wang SA et al (2023) The international consensus classification of eosinophilic disorders and systemic mastocytosis. Am J Hematol 98(8):1286\u20131306","journal-title":"Am J Hematol"},{"issue":"10","key":"663_CR48","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1182\/blood.2020007897","volume":"137","author":"W Xiao","year":"2021","unstructured":"Xiao W et al (2021) Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia. Blood 137(10):1377\u20131391","journal-title":"Blood"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-025-00663-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-025-00663-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-025-00663-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T22:02:51Z","timestamp":1760738571000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12308-025-00663-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["663"],"URL":"https:\/\/doi.org\/10.1007\/s12308-025-00663-5","relation":{},"ISSN":["1868-9256","1865-5785"],"issn-type":[{"value":"1868-9256","type":"print"},{"value":"1865-5785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"28 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is a review article for which formal consent is not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of article, informed consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"For this type of article, consent for publication is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}